Hyperbaric air mobilizes stem cells in humans; a new perspective on the hormetic dose curve

IntroductionHyperbaric air (HBA) was first used pharmaceutically in 1662 to treat lung disease. Extensive use in Europe and North America followed throughout the 19th century to treat pulmonary and neurological disorders. HBA reached its zenith in the early 20th century when cyanotic, moribund “Span...

Full description

Bibliographic Details
Published in:Frontiers in Neurology
Main Authors: Kent J. MacLaughlin, Gregory P. Barton, Rudolf K. Braun, Julia E. MacLaughlin, Jacob J. Lamers, Matthew D. Marcou, Marlowe W. Eldridge
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1192793/full

Similar Items